Hypothalamic DBS therapy improves recovery of lower limb movements after spinal cord injury

Researchers at EPFL and Lausanne University Hospital (CHUV), led by professors Grégoire Courtine and Jocelyne Bloch, have achieved a major milestone in the treatment of spinal cord injuries (SCI).

Medtronic snags first pulsed field ablation approval in US

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medtronic has gained the first

December 14, 2023

High blood sugar impairs brain health even without diabetes

A study by Baycrest found that high blood sugar may impair brain health even in people without diabetes.

December 3, 2024

Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients

Durable responses were seen when axicabtagene ciloleucel (axi-cel; Yescarta) was administered as a first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), according to

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.